While transient IL-17 expression in response to infection is protective, dysregulated IL-17 expression is thought to be foundational to the pathogenesis of several human inflammatory diseases including psoriasis, ankylosing spondylitis, rheumatoid arthritis, multiple sclerosis, and inflammatory bowel diseases4. Here, IL17A is linked to multiple sclerosis.